Genentech at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Genentech brings 10 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on quantitative pharmacology for bispecific and multispecific antibodies, including dose selection and receptor occupancy. Its sessions also cover multiplexed pharmacokinetic studies that reduce animal use and an alternative to spray drying for amorphous dispersions.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Genentech South San Francisco, CA | |
Biotechnology company in the Roche Group developing and marketing medicines in oncology, immunology, neuroscience and ophthalmology. | Poster Mon Oct 26 11:30am–12:30pm High-Throughput Multiplex In Vivo PK Quantification to Accelerate Biotherapeutic Candidate Selection and Reduce Animal Usage Poster Mon Oct 26 12:30pm–1:30pm LEAP: A Bioinformatics Framework Linking Expression to Target Abundance and Pharmacokinetics for Predicting TMDD, PK, and Dose Talk Mon Oct 26 1:30pm–2:30pm Talk Mon Oct 26 3:00pm–3:15pm Talk Mon Oct 26 3:30pm–3:45pm Talk Mon Oct 26 3:45pm–4:00pm Talk Tue Oct 27 9:30am–10:00am Talk Wed Oct 28 9:00am–9:30am Session Wed Oct 28 9:00am–11:00am Symposium: Translational Pharmacology and Quantitative Strategies for Next-Generation Anti-Cancer Biologics Talk Wed Oct 28 10:00am–10:30am |
Instantly find 20 buyers from Genentech
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction